Corporate Images - Vertex Pharmaceuticals Newsroom
WEBJeffrey Leiden Center for Cell and Genetic Therapies. DOWNLOAD.
Vertex Pharmaceuticals | Home
WEBVertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals | Our Science
WEBWe’re investing in cell and genetic therapies to build an industry-leading portfolio of technologies, teams and manufacturing capabilities. We're committed to pushing the scientific envelope by leveraging emerging therapeutic modalities that have the potential to have a transformative impact for patients who are waiting.
Clinical Trials | Vertex Pharmaceuticals
WEBFind a Vertex clinical trial. Vertex Pharmaceuticals is focused on discovering medicines for people with serious diseases. Developing innovative medicines requires carefully designed studies in humans that evaluate the safety and …
Vertex Pharmaceuticals | Our Science | Research with Us
WEBDiscover and learn more about research opportunities with Vertex Pharmaceuticals.
572 Vertex Pharmaceuticals Stock Photos & High-Res Pictures - Getty Images
WEBExplore Authentic Vertex Pharmaceuticals Stock Photos & Images For Your Project Or Campaign. Less Searching, More Finding With Getty Images.
From the Clinic to Biotech: How Vertex Hopes to Transform the …
WEBVertex has long focused on developing potentially transformative new therapies for diseases where they have a deep understanding of the underlying causal biology. Semma’s investigational research which aimed to manufacture islet cells to replace the ones missing in a person living with type 1 diabetes, aligned with Vertex’s scientific strategy.
Vertex Pharmaceuticals: Humanizing drug discovery - Nature
WEBIn 2015, Vertex became one of the first companies to implement drug product continuous manufacturing technology in the development and production of our investigational and commercial medicines.
Newsroom | Vertex Pharmaceuticals Newsroom
WEBVertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis. Read More.
Press Release - Vertex Pharmaceuticals Newsroom
WEBJun 21, 2024 · The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease, and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases.